RxDoctor Payments Data

Cynthia Shughrue, DO

Family Medicine · Dallas, TXNPI 1619941366

Payments from drug & device makers

$5,504in general payments, 2019–2025

Across 307 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$795
  • AstraZeneca$733
  • Novo Nordisk$529
  • Pfizer$460
  • GSK$443
  • AbbVie$379
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,43899%
  • Education$661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,504 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$48,053
Medicare patients
134
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$45,606
RybelsusSemaglutide22$31,568
MounjaroTirzepatide17$21,707
EliquisApixaban22$19,874
OzempicSemaglutide12$11,704
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,024
Rosuvastatin Calcium256$3,677
Levothyroxine Sodium140$1,705
Azelastine Hcl70$1,625
SynthroidLevothyroxine Sodium20$1,400
Losartan Potassium83$1,179
Albuterol Sulfate HfaAlbuterol Sulfate27$1,112
Lisinopril92$704
ProgesteroneProgesterone, Micronized14$639
Atorvastatin Calcium62$528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$58$45,60642 claims
Novo NordiskRybelsus, Ozempic$529$43,27234 claims
Lilly USA, LLCMounjaro$795$21,70717 claims
PfizerEliquis$460$19,87422 claims
GSKTrelegy Ellipta$443$10,02415 claims
AbbVieSynthroid$379$1,40020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →